Respiratory Research & Clinical Practice
Publicación de: Sociedade Brasileira de Pneumologia e Tisiologia - SBPT
Área:
Ciências Da Saúde
Versión on-line ISSN:
3086-3910
Titulo anterior
Jornal Brasileiro de Pneumologia
Tabla de contenido
Respiratory Research & Clinical Practice, Volumen: 52, Numero: 5, Publicado: 2026Respiratory Research & Clinical Practice, Volumen: 52, Numero: 5, Publicado: 2026
| Documents |
|---|
|
ORIGINAL ARTICLE Can electrical impedance tomography predict successful mechanical ventilation weaning in tracheostomized patients? A single-center observational study Pinto, Walkyria A Macedo Freitas, Flávio G R Ramos, Fernando J S Santos, Renato H N Machado, Flávia R Resumen en Inglés: ABSTRACT Objective: To evaluate whether ventilation variables monitored by electrical impedance tomography (EIT) behaved differently between tracheostomized patients who progressed successfully or failed within 6 h after withdrawal of invasive mechanical ventilation (IMV), as well as to improve the accuracy of failure prediction models. Methods: This was a single-center prospective observational study including tracheostomized adults who had been on IMV for more than seven days and who were clinically ready for discontinuation. Clinical and EIT variables-end-expiratory lung impedance, impedance variation, center of ventilation, heterogeneity index, and ventilation distribution-were collected. The primary outcome measure was IMV weaning failure within 6 h, defined as the need to resume IMV for respiratory distress. Associations between EIT variables and failure were tested by using multivariate logistic regression and ROC curves to assess predictive accuracy. Results: Fifty-nine patients were analyzed; 43 (72.9%) were successfully weaned from IMV, and 16 (27.1%) failed. In the region of interest H1 (ventral lung region), end-expiratory lung impedance decreased more markedly among successfully weaned patients (p = 0.03). Respiratory rate behavior differed between the groups over time (interaction p = 0.01), whereas other EIT variables showed no group-time interaction. In the multivariate analysis, BMI and 24-hour fluid balance were independently associated with failure. Adding EIT variables to clinical models did not improve predictive accuracy. Conclusions: The EIT variables evaluated in our study did not behave differently between tracheostomized patients who were successfully weaned from IMV and those who were not. The addition of EIT variables did not improve the accuracy of failure prediction models. |
|
ORIGINAL ARTICLE Pectoralis muscle features assessed by chest CT and their associations with clinical and functional outcomes in children and adolescents with cystic fibrosis: a cross-sectional study Costa, Mariana Severo da Amor-Barbosa, Marta Sbruzzi, Mariana Vendrusculo, Fernanda Maria Fischer, Denise Lautenschleger Carvalho, Flávia Moreira Andrade, Rubens Gabriel Feijó Pinto, Leonardo Araújo Donadio, Márcio Vinícius Fagundes Resumen en Inglés: ABSTRACT Objective: To evaluate the cross-sectional area and thickness of the pectoralis major muscle using chest CT and to investigate their associations with nutritional, respiratory, and functional parameters in children and adolescents with cystic fibrosis (CF). Methods: This was a cross-sectional study including patients 6-18 years of age with a confirmed diagnosis of CF. Anthropometric data were collected, as were data related to lung function and muscle strength assessed by dynamometry, as well as pectoralis muscle area and thickness measured by chest CT. Aerobic fitness was assessed with cardiopulmonary exercise testing. Results: The mean age of the participants was 11.2 ± 3.3 years, and the mean BMI was 17.1 ± 2.8 kg/m2. Oxygen pulse was found to correlate significantly with pectoralis muscle area (r = 0.51; p = 0.02), FEV1 (r = −0.58; p = 0.01), and BMI z-score (r = 0.60; p < 0.01). Pectoralis muscle area showed a moderate correlation with muscle strength (r = 0.42; p = 0.03), whereas muscle thickness showed only a weak association with FEV1. Conclusions: Our findings suggest that the cross-sectional area of the pectoralis muscle is a more relevant indicator of muscle function than is thickness. Integrating muscle morphology, strength, and aerobic fitness may contribute to a more comprehensive clinical assessment in patients with cystic fibrosis. |
|
ORIGINAL ARTICLE Prevalence and factors associated with the development of asthma in a cohort of children who were preterm infants and received passive immunization with palivizumab Manini, Mariana Bueno Silva, Natali Caroline da Cruz, Gabriela do Amaral Gurgel Morcillo, André Moreno Ribeiro, José Dirceu Toro, Adyléia Aparecida Dalbo Contrera Resumen en Inglés: ABSTRACT Objective: To assess the prevalence of asthma in a cohort of preterm infants, comparing those who received prophylaxis with palivizumab, a monoclonal antibody against respiratory syncytial virus (RSV), with those who did not. That is relevant because RSV infection has been linked to recurrent wheezing and asthma in childhood, but a causal relationship remains unclear. Methods: This was a prospective cohort study involving children who were preterm infants without congenital heart disease, exposed or not to palivizumab. Parents or legal guardians answered a telephone questionnaire adapted from the International Study of Asthma and Allergies in Childhood, which covers respiratory symptoms, allergy history, and potential risk factors. Results: Among 292 eligible children, 217 were included (149 in the palivizumab group and 68 in the control group). Of those 217 infants, 25.3% (95% CI:19.9-31.5%) had asthma: 24.2% (95% CI: 17.8-31.5%) in the palivizumab group and 27.9% (95% CI: 18.3-39.5%) in the control group, with no significant difference (p = 0.553). In the bivariate analysis, asthma was significantly associated with a family history of atopy (p < 0.001), parental asthma (p = 0.006), allergic rhinitis in the child (p < 0.001), and atopic dermatitis in the child (p = 0.022). In the multivariate analysis, asthma remained associated with a family history of atopy (adjusted OR = 4.16; 95% CI: 1.77-9.79), allergic rhinitis in the child (adjusted OR = 5.10; 95% CI: 2.59-10.02), and parental asthma (adjusted OR = 2.45; 95% CI: 1.19-5.04). Conclusions: Palivizumab does not seem to protect against asthma development in preterm infants without congenital heart disease. A family history of atopy, parental asthma, and allergic rhinitis in the child seem to be the primary determinants of asthma risk in such infants. |
|
ORIGINAL ARTICLE Real-world outcomes of elexacaftor/tezacaftor/ivacaftor in a cohort of children and adolescents with cystic fibrosis in Brazil Cohen, Renata Wrobel Folescu Coelho, Paloma Fernandes Rocha, Leonardo Yllel Moreira, Julia Vieira da Cunha Barboza, Natália Marins, Katty Anne Carvalho Meyer, Viviane Mauro Correa Costa, Patrícia Fernandes Barreto Machado Folescu, Tania Wrobel Resumen en Inglés: ABSTRACT Objective: To describe real-world clinical outcomes associated with elexacaftor/tezacaftor/ivacaftor (ETI) in people with cystic fibrosis (pwCF) followed at a pediatric referral center in Brazil. Methods: This was a retrospective analysis nested within a prospective cohort study conducted between February of 2023 and February of 2026. We included individuals who had confirmed cystic fibrosis; who had initiated treatment with ETI; and who were followed for at least six months. Outcomes assessed included BMI-for-age z-score (BAZ), percent predicted FEV1, sweat chloride concentration (SCC), microbiological data, and adverse events. Data were collected from baseline prior to ETI initiation and from follow-up visits at 6-12 months after initiation of ETI treatment. Results: A total of 108 pwCF (males, 50.9%; mean age, 10.2 ± 3.7 years) were included. Genotypes were F/F (46.3%), F/non-F (47.2%), and non-F/non-F (6.5%). ETI was associated with significant improvements in BAZ and FEV1 percentage points (ppFEV1), with a mean individual increase of 16.9 percentage points in lung function. Median SCC decreased from 95 mmol/L to 41 mmol/L, with most pwCF falling below the diagnostic threshold. No significant correlation was observed between SCC reduction and changes in BAZ or ppFEV1. The proportion of individuals with at least one positive respiratory culture for Pseudomonas aeruginosa declined from 54.63% before ETI to 23.58% within 6-12 months of treatment (p < 0.0001). Adverse events were mild: 5.6% developed rash requiring temporary interruption; two had elevated creatine phosphokinase levels; and no clinically significant liver enzyme elevation or permanent discontinuation occurred. Conclusions: ETI was effective and well tolerated, leading to meaningful improvements in nutritional status, lung function, and cystic fibrosis transmembrane conductance regulator restoration, as well as to reduced P. aeruginosa detection, in this real-world pediatric cohort. |
|
LETTERS TO THE EDITOR Lymphangioleiomyomatosis diagnosed by transbronchial lung cryobiopsy in a patient with hemoptysis: a case report Bridi, Guilherme das Posses Amaral, Alexandre Franco Vaz, Luiza Escañuela Vicente, Gustavo Nogueira Schincariol Lima, Evelise Nascimento, Ellen Caroline Toledo do Kairalla, Ronaldo Adib Baldi, Bruno Guedes |
Sociedade Brasileira de Pneumologia e Tisiologia - SBPT
SCS Quadra 01, Bloco K, Salas 203/204 Ed. Denasa, Brasília - DF CEP: 70.398-900, Fone/fax: 08000 61 6218, (61) 3245 1030 e (61) 3245 6218 -
Brasília -
DF -
Brazil
E-mail: rrcp@sbpt.org.br
E-mail: rrcp@sbpt.org.br
Lea la Declaración de Acceso abierto
